Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

UBE2L3 anticorps (AA 81-154) (Biotin)

Cet anticorps Lapin Polyclonal détecte spécifiquement UBE2L3 dans WB, ELISA, IHC (p) et IHC (fro). Il présente une réactivité envers Humain.
N° du produit ABIN1398571

Aperçu rapide pour UBE2L3 anticorps (AA 81-154) (Biotin) (ABIN1398571)

Antigène

Voir toutes UBE2L3 Anticorps
UBE2L3 (Ubiquitin-Conjugating Enzyme E2L 3 (UBE2L3))

Reactivité

  • 61
  • 16
  • 13
  • 7
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
Humain

Hôte

  • 57
  • 3
  • 1
Lapin

Clonalité

  • 56
  • 5
Polyclonal

Conjugué

  • 34
  • 5
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp UBE2L3 est conjugé à/à la Biotin

Application

  • 56
  • 27
  • 24
  • 13
  • 13
  • 12
  • 10
  • 8
  • 6
  • 2
  • 2
  • 1
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
  • Épitope

    • 14
    • 9
    • 8
    • 8
    • 7
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 81-154

     Réactivité croisée

    Humain

    Homologie

    Mouse,Rat,Cow,Sheep,Horse,Rabbit,Zebrafish

    Purification

    Purified by Protein A.

    Immunogène

    KLH conjugated synthetic peptide derived from human Ube2L3

    Isotype

    IgG
  • Indications d'application

    WB 1:300-5000
    IHC-P 1:200-400
    IHC-F 1:100-500

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 μg/μL

    Buffer

    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

    Agent conservateur

    ProClin

    Précaution d'utilisation

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Stock

    -20 °C

    Stockage commentaire

    Store at -20°C for 12 months.

    Date de péremption

    12 months
  • Antigène

    UBE2L3 (Ubiquitin-Conjugating Enzyme E2L 3 (UBE2L3))

    Autre désignation

    Ube2L3

    Sujet

    Synonyms: E2 F1, E2-F1, L UBC, L-UBC, UB2L3_HUMAN, UBCE7, UbcH7, UbcM4, Ube2l3, Ubiquitin carrier protein L3, Ubiquitin conjugating enzyme E2 L3, Ubiquitin protein ligase L3, Ubiquitin-conjugating enzyme E2 L3, Ubiquitin-conjugating enzyme E2-F1, Ubiquitin-protein ligase L3.

    Background: The ubiquitin (Ub) pathway involves three sequential enzymatic steps that facilitate the conjugation of Ub and Ub-like molecules to specific protein substrates. The first step requires the ATP-dependent activation of the Ub C-terminus and the assembly of multi-Ub chains by the Ub-activating enzyme known as the E1 component. The Ub chain is then conjugated to the Ub-conjugating enzyme (E2) to generate an intermediate Ub-E2 complex. The Ub-ligase (E3) then catalyzes the transfer of Ub from E2 to the appropriate protein substrate. UBE2E1 and UBE2L3, also designated UBCH6 and UBCH7 respectively in human, are E2 conjugating enzymes that interact with various proteins. Specifically, UBE2E1 interacts with the tumor suppressor protein TSSC5. UBE2L3 has been shown to mediate c-fos degradation, NF-kB maturation, human papilloma virus-mediated p53 and Myc protein degradation.

    ID gène

    7332
Vous êtes ici:
Chat with us!